Abstract
IntroductionTenofovir and Entecavir are potent oral antivirals (OAV’s) and leading agents in the treatment of Chronic Hepatitis B (CHB). Despite this, they have limited ability to reduce HBsAg, thus indefinite...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have